"It still affects our economic situation": long-term economic burden of breast cancer and lymphedema.
Lorraine T DeanShadiya L MossYusuf RansomeLivia Frasso-JaramilloYuehan ZhangKala VisvanathanLauren Hersch NicholasKathryn H SchmitzPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)
Long-term cancer survivors with lymphedema may face up to 112% higher out-of-pocket costs than those without lymphedema, which influences lymphedema management, and has lasting impact on savings and productivity. Findings reinforce the need for actions at policy, provider, and individual patient levels, to reduce lymphedema costs. Future work should explore patient-driven recommendations to reduce economic burden after cancer.